☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Disorders
Verily‘s Study Watch Receives FDA's 510 (k) Clearance for Cardiovascular Disorders
January 22, 2019
Axovant Sciences Licenses Two Gene Therapy Programs from University of Massachusetts for Rare and Fatal Neurodegenerative Genetic...
December 14, 2018
Sanofi and Denali Therapeutics Collaborates to Develop & Commercialize Clinical Candidates for Neurology and Inflammatory Diso...
November 1, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.